Safety and Antihypertensive Effect of Selara® (Eplerenone): Results from a Postmarketing Surveillance in Japan

Figure 1

Changes in systolic (open square) and diastolic (closed square) blood pressure at each observation time point from baseline to week 12 (mean ± standard deviation) during the 12-week treatment period in the effectiveness analysis population.